• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 27-11-2025: Press Release

    27-11-2025 | 04:28 pm

    Zydus received tentative USFDA approval for its Empagliflozin and Linagliptin Tablets, targeting Type 2 diabetes. This opens access to a US market with annual sales of USD 215.8 mn.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited